181 related articles for article (PubMed ID: 24452641)
1. Tonabersat for migraine prophylaxis: a systematic review.
Cao Y; Zheng OJ
Pain Physician; 2014; 17(1):1-8. PubMed ID: 24452641
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
Goadsby PJ; Ferrari MD; Csanyi A; Olesen J; Mills JG;
Cephalalgia; 2009 Jul; 29(7):742-50. PubMed ID: 19222510
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.
Dahlöf CG; Hauge AW; Olesen J
Cephalalgia; 2009 Nov; 29 Suppl 2():7-16. PubMed ID: 19723121
[TBL] [Abstract][Full Text] [Related]
4. Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study.
Hauge AW; Asghar MS; Schytz HW; Christensen K; Olesen J
Lancet Neurol; 2009 Aug; 8(8):718-23. PubMed ID: 19570717
[TBL] [Abstract][Full Text] [Related]
5. Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine.
Silberstein SD; Schoenen J; Göbel H; Diener HC; Elkind AH; Klapper JA; Howard RA
Cephalalgia; 2009 Nov; 29 Suppl 2():17-27. PubMed ID: 19723122
[TBL] [Abstract][Full Text] [Related]
6. Feverfew for preventing migraine.
Pittler MH; Ernst E
Cochrane Database Syst Rev; 2004; (1):CD002286. PubMed ID: 14973986
[TBL] [Abstract][Full Text] [Related]
7. Tonabersat for migraine prevention: new life or last gasp?
Dodick DW
Lancet Neurol; 2009 Aug; 8(8):693-5. PubMed ID: 19570718
[No Abstract] [Full Text] [Related]
8. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
9. Tonabersat, a novel gap-junction modulator for the prevention of migraine.
Silberstein SD
Cephalalgia; 2009 Nov; 29 Suppl 2():28-35. PubMed ID: 19723123
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic treatment of migraine in children: a systematic review of medication trials.
Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
[TBL] [Abstract][Full Text] [Related]
12. Antiepileptics in migraine prophylaxis: an updated Cochrane review.
Mulleners WM; McCrory DC; Linde M
Cephalalgia; 2015 Jan; 35(1):51-62. PubMed ID: 25115844
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
14. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam as preventive treatment in adults with migraine: an up-to-date systematic review and quantitative meta-analysis.
Tsaousi G; Pourzitaki C; Siafis S; Kyrgidis A; Grosomanidis V; Kouvelas D; Papazisis G
Eur J Clin Pharmacol; 2020 Feb; 76(2):161-174. PubMed ID: 31768574
[TBL] [Abstract][Full Text] [Related]
16. Magnesium in Migraine Prophylaxis-Is There an Evidence-Based Rationale? A Systematic Review.
von Luckner A; Riederer F
Headache; 2018 Feb; 58(2):199-209. PubMed ID: 29131326
[TBL] [Abstract][Full Text] [Related]
17. Topiramate for migraine prevention: a randomized controlled trial.
Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
[TBL] [Abstract][Full Text] [Related]
18. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature].
Reveiz-Herault L; Cardona AF; Ospina EG; Carrillo P
Rev Neurol; 2003 May 16-31; 36(10):907-12. PubMed ID: 12766861
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
